{
  "id": 19645662,
  "title": "STAT+: Alnylam, once in the hunt to be a $100 billion biotech, needs to solve its heart drug problem",
  "url": "https://urgent.news/2026/11/12/stat-alnylam-once-in-the-hunt-to-be-a-100-billion-biotech-needs-to",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-12T11:30:00.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/11/12/alnylam-amvuttra-heart-drug-growth/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Alnylam is heavily dependent on its heart drug Amvuttra for growth — and sales have been slowing.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}